Market Development Limitation Sample Clauses

Market Development Limitation. (a) The Management Company shall not at any time during the period beginning on the Commencement Date and ending on May 31, 1998 (the "Exclusivity Period"), without the prior written consent of the Medical Group (which consent shall not be unreasonably withheld), provide management services substantially similar to those provided to the Medical Group hereunder to any orthopedic surgeon or group of orthopedic surgeons (other than OSA and Lauderdale Orthopaedic Surgeons) that practices in the Combined Exclusivity Area (as hereinafter defined) nor shall the Management Company employ any such orthopaedic surgeon; provided, however, that notwithstanding the foregoing restrictions, the Management Company may, without the consent of the Medical Group, provide contract management services to an independent physician association. In the event that the Medical Group has combined with OSA on or before May 31, 1998, the Exclusivity Period shall be extended to August 31, 2000; provided, that if the Medical Group, as combined, consists of at least 15 practicing orthopedic surgeons as of August 31, 2000, the Exclusivity Period shall extend throughout the Term, but if the Medical Group, as
Sample 1
AutoNDA by SimpleDocs
Market Development Limitation. 92 16.4 Physician Advisory Board ...................................... 94 16.5
Sample 1
Market Development Limitation. The Management Company shall not at any time during the period beginning on
Sample 1
Market Development Limitation. (a) The Management Company shall not at any time during the period beginning on the Commencement Date and ending on November 1, 1998 (the "Exclusivity Period"), without the prior written consent of the Medical Group (which consent shall not be unreasonably withheld), enter into a management services agreement substantially similar to this Agreement with any orthopedic surgeon or group of orthopedic surgeons that practices in the Medical Group Service Area (as hereinafter defined); provided, however, that notwithstanding the foregoing restrictions, the Management Company may, without the consent of the Medical Group, provide contract management services to an independent physician association. In the event that the Medical Group has assisted the Management Company to enter into management services agreements pursuant to which the Management Company provides management services to at least 12 physicians practicing in the Medical Group Service Area (not including any physician stockholders or employees of the Medical Group) by November 1, 2001, and in connection therewith the Medical Group does earn 30,000 shares of common stock of the Management Company pursuant to Schedule III hereof, then the Exclusivity Period shall extend throughout the Term; provided that if at any time during the Term the total number of physicians to which the Management Company provides management services in the Medical
Sample 1

Related to Market Development Limitation

  • Joint Development All inventions, know-how, trade secrets, data or information which result from joint development by the Parties hereto shall be jointly owned by the Parties. The Parties hereby agree to cooperate in good faith in the filing of any and all patent applications in all jurisdictions.

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Clinical Development (a) Stellartech shall design, develop and construct a Clinical Unit for each of the Thermage Disposable Device and the Thermage Generator, and any required component or subassembly thereof and shall deliver such Clinical Units to Thermage in accordance with the Development Program; (b) Stellartech shall deliver to Thermage such other Deliverables as are contemplated by the Development Program in accordance with the Development Program; and (c) as requested by Thermage and automatically at the conclusion of the Development Program, Stellartech, so long as Thermage is not in breach of its material obligation hereunder, shall deliver in writing to Thermage any and all data and information held by or in the control of Stellartech which is necessary or useful to obtain regulatory approval of the Products in the United States or any foreign country.

  • Research and Development (i) Advice and assistance in relation to research and development of Party B;

  • Information Systems Acquisition Development and Maintenance a. Client Data – Client Data will only be used by State Street for the purposes specified in this Agreement.

  • Research Independence The Company acknowledges that each Underwriter’s research analysts and research departments, if any, are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriter’s research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter’s investment banking divisions. The Company acknowledges that the Representative is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or equity securities of the Company.

  • Condominiums/Planned Unit Developments If the Mortgaged Property is a condominium unit or a planned unit development (other than a de minimis planned unit development) such condominium or planned unit development project such Mortgage Loan was originated in accordance with, and the Mortgaged Property meets the guidelines set forth in the Originator's Underwriting Guidelines;

  • Independent Development The Disclosing Party acknowledges that the Receiving Party may currently or in the future be developing information internally, or receiving information from other parties, that is similar to the Confidential Information. Accordingly, nothing in this Agreement will be construed as a representation or agreement that the Receiving Party will not develop or have developed for it products, concepts, systems or techniques that are similar to or compete with the products, concepts, systems or techniques contemplated by or embodied in the Confidential Information, provided that the Receiving Party does not violate any of its obligations under this Agreement in connection with such development.

  • Subsequent Developments After the date of this Contract and until the Closing Date, Seller shall use best efforts to keep Buyer fully informed of all subsequent developments of which Seller has knowledge (“Subsequent Developments”) which would cause any of Seller’s representations or warranties contained in this Contract to be no longer accurate in any material respect.

  • Status as Business Development Company The Borrower is an “investment company” that has elected to be regulated as a “business development company” within the meaning of the Investment Company Act and qualifies as a RIC.

Time is Money Join Law Insider Premium to draft better contracts faster.